Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 894

1.

Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials.

Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR Jr, Fuller CD, VanderWalde NA.

J Geriatr Oncol. 2019 Nov 8. pii: S1879-4068(19)30348-0. doi: 10.1016/j.jgo.2019.11.001. [Epub ahead of print]

PMID:
31711757
2.

Sea Change: A Decade of IMRT for Treatment of Breast Cancer.

Smith GL, Smith BD.

J Natl Cancer Inst. 2019 Oct 24. pii: djz199. doi: 10.1093/jnci/djz199. [Epub ahead of print] No abstract available.

PMID:
31647554
3.

"Après Mois, Le Déluge": Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era.

Kiser KJ, Smith BD, Wang J, Fuller CD.

Front Oncol. 2019 Sep 30;9:983. doi: 10.3389/fonc.2019.00983. eCollection 2019. Review.

4.

High affinity threading of a new tetralactam macrocycle in water by fluorescent deep-red and near-infrared squaraine dyes.

Dempsey JM, Zhai C, McGarraugh HH, Schreiber CL, Stoffel SE, Johnson A, Smith BD.

Chem Commun (Camb). 2019 Nov 4;55(85):12793-12796. doi: 10.1039/c9cc05244e. Epub 2019 Oct 8.

PMID:
31593200
5.

Croconaine Rotaxane Dye with 984 nm Absorption: Wavelength-Selective Photothermal Heating.

McGarraugh HH, Liu W, Matthews BP, Smith BD.

European J Org Chem. 2019 Jun 10;2019(21):3489-3494. doi: 10.1002/ejoc.201900082. Epub 2019 Feb 18.

PMID:
31579392
6.

A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation.

Pratz KW, Rudek MA, Smith BD, Karp J, Gojo I, Dezern A, Jones RJ, Greer J, Gocke C, Baer MR, Duong VH, Rosner G, Zahurak M, Wright JJ, Emadi A, Levis M; ETCTN-8922 study team.

Biol Blood Marrow Transplant. 2019 Sep 21. pii: S1083-8791(19)30634-2. doi: 10.1016/j.bbmt.2019.09.023. [Epub ahead of print]

PMID:
31550496
7.

Epilogue: Treatment Plan.

Bagley AF, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):475-476. doi: 10.1016/j.ijrobp.2019.08.046. No abstract available.

PMID:
31540594
8.

Radiated, Reconstructed, Recurred.

Bagley AF, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):471-472. doi: 10.1016/j.ijrobp.2019.05.070. No abstract available.

PMID:
31540590
9.

Minimum Data Elements for Radiation Oncology: An American Society for Radiation Oncology Consensus Paper.

Hayman JA, Dekker A, Feng M, Keole SR, McNutt TR, Machtay M, Martin NE, Mayo CS, Pawlicki T, Smith BD, Kudner R, Dawes S, Yu JB.

Pract Radiat Oncol. 2019 Nov;9(6):395-401. doi: 10.1016/j.prro.2019.07.017. Epub 2019 Aug 21.

10.

Anatomically Optimizing Reirradiation.

Augustyn A, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):19. doi: 10.1016/j.ijrobp.2018.09.036. No abstract available.

PMID:
31422806
11.

Sex-Based Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E.

J Natl Cancer Inst. 2019 Jul 27. pii: djz154. doi: 10.1093/jnci/djz154. [Epub ahead of print]

PMID:
31350545
12.

Neoadjuvant Radiotherapy to Facilitate Immediate Breast Reconstruction: A Systematic Review and Current Clinical Trials.

Singh P, Hoffman K, Schaverien MV, Krause KJ, Butler C, Smith BD, Kuerer HM.

Ann Surg Oncol. 2019 Oct;26(10):3312-3320. doi: 10.1245/s10434-019-07538-x. Epub 2019 Jul 24.

PMID:
31342362
13.

Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.

Sun S, van la Parra RFD, Rauch GM, Checka C, Tadros AB, Lucci A Jr, Teshome M, Black D, Hwang RF, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM.

Ann Surg Oncol. 2019 Oct;26(10):3071-3079. doi: 10.1245/s10434-019-07533-2. Epub 2019 Jul 24.

PMID:
31342361
14.

Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.

Hambley BC, Norsworthy KJ, Jasem J, Zimmerman JW, Shenderov E, Webster JA, Showel MM, Gondek LP, Dalton WB, Prince G, Gladstone DE, Streiff MB, Pratz KW, Gojo I, Ghiaur G, Levis MJ, Smith BD, DeZern AE.

Leuk Res. 2019 Aug;83:106174. doi: 10.1016/j.leukres.2019.106174. Epub 2019 Jun 21. No abstract available.

PMID:
31255938
15.

Breast cancer and aging: Standing on the shoulders of a giant.

Karuturi MS, Sedrak MS, Magnuson A, Freedman R, Jatoi A, Smith BD, Kimmick GG.

J Geriatr Oncol. 2019 Jun 11. pii: S1879-4068(19)30185-7. doi: 10.1016/j.jgo.2019.05.019. [Epub ahead of print] Review.

PMID:
31201096
16.

Side effects from acute myeloid leukemia treatment: results from a national survey.

Crossnohere NL, Richardson DR, Reinhart C, O'Donoghue B, Love SM, Smith BD, Bridges JFP.

Curr Med Res Opin. 2019 Nov;35(11):1965-1970. doi: 10.1080/03007995.2019.1631149. Epub 2019 Jun 26.

PMID:
31188058
17.

Molecular recognition using tetralactam macrocycles with parallel aromatic sidewalls.

Li DH, Smith BD.

Beilstein J Org Chem. 2019 May 9;15:1086-1095. doi: 10.3762/bjoc.15.105. eCollection 2019. Review.

18.

Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas CR Jr, Fuller CD.

JAMA Oncol. 2019 Jun 3. doi: 10.1001/jamaoncol.2019.2055. [Epub ahead of print]

PMID:
31158272
19.

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.

Smith BD, Kaufman MD, Lu WP, Gupta A, Leary CB, Wise SC, Rutkoski TJ, Ahn YM, Al-Ani G, Bulfer SL, Caldwell TM, Chun L, Ensinger CL, Hood MM, McKinley A, Patt WC, Ruiz-Soto R, Su Y, Telikepalli H, Town A, Turner BA, Vogeti L, Vogeti S, Yates K, Janku F, Abdul Razak AR, Rosen O, Heinrich MC, Flynn DL.

Cancer Cell. 2019 May 13;35(5):738-751.e9. doi: 10.1016/j.ccell.2019.04.006.

PMID:
31085175
20.

Long-term decision regret surrounding systemic therapy in older breast cancer survivors: A population-based survey study.

Karuturi MS, Lei X, Shen Y, Giordano SH, Swanick CW, Smith BD.

J Geriatr Oncol. 2019 Nov;10(6):973-979. doi: 10.1016/j.jgo.2019.03.013. Epub 2019 Mar 30.

PMID:
30940493
21.

Time-lapse imaging of cell death in cell culture and whole living organisms using turn-on deep-red fluorescent probes.

Jarvis TS, Roland FM, Dubiak KM, Huber PW, Smith BD.

J Mater Chem B. 2018 Aug 14;6(30):4963-4971. doi: 10.1039/C8TB01495G. Epub 2018 Jul 10.

22.

Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.

Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):574-581. doi: 10.1016/j.ijrobp.2019.02.049. Epub 2019 Mar 6.

PMID:
30851348
23.

Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives.

Logan JK, Jiang J, Shih YT, Lei X, Xu Y, Hoffman KE, Giordano SH, Smith BD.

J Oncol Pract. 2019 Apr;15(4):e356-e368. doi: 10.1200/JOP.18.00588. Epub 2019 Mar 8.

PMID:
30849005
24.

Stabilization and Extraction of Fluoride Anion Using a Tetralactam Receptor.

Liu W, Oliver AG, Smith BD.

J Org Chem. 2019 Apr 5;84(7):4050-4057. doi: 10.1021/acs.joc.9b00042. Epub 2019 Mar 12.

PMID:
30827107
25.

Nucleophilic addition of phosphorus(iii) derivatives to squaraines: colorimetric detection of transition metal-mediated or thermal reversion.

Bacher EP, Lepore AJ, Pena-Romero D, Smith BD, Ashfeld BL.

Chem Commun (Camb). 2019 Mar 18;55(22):3286-3289. doi: 10.1039/c9cc01243e. Epub 2019 Feb 27.

PMID:
30810572
26.

Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.

Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo M, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI.

Laryngoscope. 2019 Feb 12. doi: 10.1002/lary.27873. [Epub ahead of print]

PMID:
30756394
27.

Y2O3 optical constants between 5 nm and 50 nm.

Muhlestein JB, Smith BD, Miles M, Thomas SM, Willey A, Allred DD, Turley RS.

Opt Express. 2019 Feb 4;27(3):3324-3336. doi: 10.1364/OE.27.003324.

PMID:
30732355
28.

Shape-Selective Recognition of Quaternary Ammonium Chloride Ion Pairs.

Li DH, Smith BD.

J Org Chem. 2019 Mar 1;84(5):2808-2816. doi: 10.1021/acs.joc.8b03197. Epub 2019 Feb 15.

PMID:
30730144
29.

Local Therapy Decisional Regret in Older Women With Breast Cancer: A Population-Based Study.

Advani PG, Lei X, Swanick CW, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):383-391. doi: 10.1016/j.ijrobp.2019.01.089. Epub 2019 Feb 1.

PMID:
30716524
30.

The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.

Webster J, Smith BD.

Clin Ther. 2019 Feb;41(2):336-349. doi: 10.1016/j.clinthera.2018.12.013. Epub 2019 Jan 30. Review.

31.

Implementing an Electronic Data Capture System to Improve Clinical Workflow in a Large Academic Radiation Oncology Practice.

Pasalic D, Reddy JP, Edwards T, Pan HY, Smith BD.

JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.18.00034.

32.

Ancient DNA reveals the timing and persistence of organellar genetic bottlenecks over 3,000 years of sunflower domestication and improvement.

Wales N, Akman M, Watson RHB, Sánchez Barreiro F, Smith BD, Gremillion KJ, Gilbert MTP, Blackman BK.

Evol Appl. 2018 Feb 13;12(1):38-53. doi: 10.1111/eva.12594. eCollection 2019 Jan.

33.

Do Internal Mammary Nodes Matter?

Caudle AS, Smith BD.

Ann Surg Oncol. 2019 Apr;26(4):930-932. doi: 10.1245/s10434-018-07152-3. Epub 2019 Jan 7. No abstract available.

PMID:
30617872
34.

Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.

McCurdy SR, Kanakry CG, Tsai HL, Gojo I, Smith BD, Gladstone DE, Bolaños-Meade J, Borrello I, Matsui WH, Swinnen LJ, Huff CA, Brodsky RA, Ambinder RF, Fuchs EJ, Rosner GL, Jones RJ, Luznik L.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1128-1135. doi: 10.1016/j.bbmt.2018.12.767. Epub 2018 Dec 30.

35.

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.

Cortes JE, Heidel FH, Hellmann A, Fiedler W, Smith BD, Robak T, Montesinos P, Pollyea DA, DesJardins P, Ottmann O, Ma WW, Shaik MN, Laird AD, Zeremski M, O'Connell A, Chan G, Heuser M.

Leukemia. 2019 Feb;33(2):379-389. doi: 10.1038/s41375-018-0312-9. Epub 2018 Dec 16.

36.

New tetralactam hosts for squaraine dyes.

Dempsey JM, Zhang QW, Oliver AG, Smith BD.

Org Biomol Chem. 2018 Nov 28;16(46):8976-8983. doi: 10.1039/c8ob02596g.

PMID:
30418456
37.

Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.

Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD.

J Clin Oncol. 2018 Oct 31:JCO1800317. doi: 10.1200/JCO.18.00317. [Epub ahead of print]

PMID:
30379626
38.

The Importance of Addressing Depression and Diabetes Distress in Adults with Type 2 Diabetes.

Owens-Gary MD, Zhang X, Jawanda S, Bullard KM, Allweiss P, Smith BD.

J Gen Intern Med. 2019 Feb;34(2):320-324. doi: 10.1007/s11606-018-4705-2. Epub 2018 Oct 22.

PMID:
30350030
39.

Hepatitis C care cascade among persons born 1945-1965: 3 medical centers.

Brady JE, Vellozzi C, Hariri S, Kruger DL, Nerenz DR, Brown KA, Federman AD, Krauskopf K, Kil N, Massoud OI, Wise JM, Seay TA, Smith BD, Yartel AK, Rein DB.

Am J Manag Care. 2018 Sep;24(9):421-427.

40.

Racial disparities in guideline-concordant cancer care and mortality in the United States.

Fang P, He W, Gomez D, Hoffman KE, Smith BD, Giordano SH, Jagsi R, Smith GL.

Adv Radiat Oncol. 2018 May 4;3(3):221-229. doi: 10.1016/j.adro.2018.04.013. eCollection 2018 Jul-Sep.

41.

Fluorescent Thienothiophene-Containing Squaraine Dyes and Threaded Supramolecular Complexes with Tunable Wavelengths between 600⁻800 nm.

Liu W, McGarraugh HH, Smith BD.

Molecules. 2018 Sep 1;23(9). pii: E2229. doi: 10.3390/molecules23092229.

42.

A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer.

Van Wyhe RD, Caudle AS, Shaitelman SF, Perkins GH, Buchholz TA, Hoffman KE, Strom EA, Smith BD, Tereffe W, Woodward WA, Stauder MC.

Adv Radiat Oncol. 2018 Feb 26;3(3):252-257. doi: 10.1016/j.adro.2018.02.007. eCollection 2018 Jul-Sep.

43.

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology.

Radich JP, Deininger M, Abboud CN, Altman JK, Berman E, Bhatia R, Bhatnagar B, Curtin P, DeAngelo DJ, Gotlib J, Hobbs G, Jagasia M, Kantarjian HM, Maness L, Metheny L, Moore JO, Pallera A, Pancari P, Patnaik M, Purev E, Rose MG, Shah NP, Smith BD, Snyder DS, Sweet KL, Talpaz M, Thompson J, Yang DT, Gregory KM, Sundar H.

J Natl Compr Canc Netw. 2018 Sep;16(9):1108-1135. doi: 10.6004/jnccn.2018.0071.

PMID:
30181422
44.

Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy.

Stecklein SR, Shaitelman SF, Babiera GV, Bedrosian I, Black DM, Ballo MT, Arzu I, Strom EA, Reed VK, Dvorak T, Smith BD, Woodward WA, Hoffman KE, Schlembach PJ, Kirsner SM, Nelson CL, Yang J, Guerra W, Dibaj S, Bloom ES.

Pract Radiat Oncol. 2019 Jan;9(1):e4-e13. doi: 10.1016/j.prro.2018.08.003. Epub 2018 Aug 17.

PMID:
30125673
45.

Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML).

Zeidner JF, Foster MC, Blackford AL, Litzow MR, Morris LE, Strickland SA, Lancet JE, Bose P, Levy MY, Tibes R, Gojo I, Gocke CD, Rosner GL, Little RF, Wright JJ, Doyle LA, Smith BD, Karp JE.

Leuk Res. 2018 Sep;72:92-95. doi: 10.1016/j.leukres.2018.08.005. Epub 2018 Aug 10. No abstract available.

PMID:
30118897
46.

Molecular Imaging of Aminopeptidase N in Cancer and Angiogenesis.

Schreiber CL, Smith BD.

Contrast Media Mol Imaging. 2018 Jun 25;2018:5315172. doi: 10.1155/2018/5315172. eCollection 2018. Review.

47.

Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD.

JAMA Oncol. 2018 Dec 1;4(12):1751-1757. doi: 10.1001/jamaoncol.2018.2583.

48.

Non-Covalently Pre-Assembled High-Performance Near-Infrared Fluorescent Molecular Probes for Cancer Imaging.

Shaw SK, Liu W, Gómez Durán CFA, Schreiber CL, Betancourt Mendiola ML, Zhai C, Roland FM, Padanilam SJ, Smith BD.

Chemistry. 2018 Sep 18;24(52):13821-13829. doi: 10.1002/chem.201801825. Epub 2018 Aug 19.

49.

American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation.

DeSnyder SM, Hunt KK, Dong W, Smith BD, Moran MS, Chavez-MacGregor M, Shen Y, Kuerer HM, Lucci A.

Ann Surg Oncol. 2018 Oct;25(10):2965-2974. doi: 10.1245/s10434-018-6580-9. Epub 2018 Jul 9.

PMID:
29987598
50.

Response of phase I and II detoxification enzymes, glutathione, metallothionein and acetylcholine esterase to mercury and dimethoate in signal crayfish (Pacifastacus leniusculus).

Gunderson MP, Nguyen BT, Cervantes Reyes JC, Holden LL, French JMT, Smith BD, Lineberger C.

Chemosphere. 2018 Oct;208:749-756. doi: 10.1016/j.chemosphere.2018.05.183. Epub 2018 May 30.

Supplemental Content

Loading ...
Support Center